Concise, protecting group free total syntheses of (+)-sattabacin and (+)-4-hydroxysattabacin

Tetrahedron Letters

Volumn 51, Issue 49, 2010, Pages 6375-6377

  Aronoff, Matthew R ^a   Bourjaily, Neil A ^a   Miller, Kenneth A ^a  

^a FORT LEWIS COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYSATTABACIN; NATURAL PRODUCT; SATTABACIN; UNCLASSIFIED DRUG;

ARTICLE; DIAZOTIZATION; DRUG SCREENING; DRUG SYNTHESIS; NUCLEAR MAGNETIC RESONANCE; OPTICAL ROTATION; STRUCTURE ACTIVITY RELATION;

EID: 78149284460     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2010.09.147     Document Type: Article

References (12)

1. G. Lampis, D. Deidda, C. Maullu, M.A. Madeddu, R. Pompei, F.D. Monache, and G. Satta J. Antibiot. 48 1995 967 972
2. C.S. Crumpacker, and P.A. Schaffer Nat. Med. 8 2002 327 328
3. H.J. Schaeffer, L. Beauchamp, P. De Miranda, G.B. Elion, D.J. Bauer, and P. Collins Nature 272 1978 583 585
4. C.M. Perry, and D. Faulds Drugs 52 1996 754 772
5. M.R. Keating Mayo Clin. Proc. 74 1999 1266 1283
6. D.W. Kimberlin, C.S. Crumpacker, S.E. Straus, K.K. Biron, W.L. Drew, F.G. Hayden, M. McKinlay, D.D. Richman, and R.J. Whitley Antiviral Res. 26 1995 423 438
7. D.M. Coen, and P.A. Schaffer Nat. Rev. Drug Disc. 2 2003 278 288
8. Walsh and co-workers mistakenly reported a racemic synthesis of sattabacin in 2008, but the structure of the compound they synthesized does not match that of the natural product. The hydroxyl group and ketone are transposed. See: H. Li, P.J. Carroll, and P.J. Walsh J. Am. Chem. Soc. 130 2008 3521 3531
9. P.S. Baran, T.J. Maimone, and J.M. Richter Nature 446 2007 404 408
10. S.G. Cohen, and S.Y. Weinstein J. Am. Chem. Soc. 86 1964 5326 5330
11. T. Storz, P. Dittmar, P.F. Fauquex, P. Marschal, W.U. Lottenbach, and H. Steiner Org. Process Res. Dev. 7 2003 559 570
12. Z. Wang, B. La, and J.M. Fortunak Tetrahedron Lett. 39 1998 5501 5504